MAVYRET Patient Assistance Program
Don’t let the cost of hepatitis C treatment stand between you and a cure. We help eligible patients access Mavyret (glecaprevir/pibrentasvir) for as little as $69.95 per
month through manufacturer Patient Assistance Programs.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Mavyret is an FDA-approved curative treatment for chronic hepatitis C that works against all six major genotypes — offering an 8-week path to being virus-free for most treatment-naive patients without cirrhosis.
- A full treatment course (84 tablets, 8 weeks) costs approximately $12,900–$16,901 without insurance, even with the best discount coupons (verified April 2026).
- AffordMyPrescriptions provides access to Mavyret for just $69.95/month during treatment — turning a potential $16,901 bill into approximately $140–$210 total.
- There is no generic version of Mavyret available, and the medication often requires prior authorization.
What is Mavyret Prescription Assistance Program?
TThe Mavyret Prescription Assistance Program is a manufacturer-sponsored initiative that provides Mavyret at no medication cost to qualifying patients. The program is available to uninsured and underinsured U.S. residents who meet income and residency requirements. If approved, you receive your full course of treatment at no cost.
Hepatitis C is a curable disease — but only if you can access the cure. Untreated, chronic hepatitis C silently destroys your liver over years and decades. When a medication exists that can permanently eliminate the virus from your body in as little as 8 weeks, cost should never be the reason you don’t receive it. Yet at nearly $17,000 for a full treatment course, Mavyret is out of reach for most uninsured Americans.
AffordMyPrescriptions eliminates that barrier. For $69.95 per month during your treatment period, our Patient Advocates manage every step of your enrollment. Medicare Part D patients are accepted.
Pharmacy Price Comparison
- Without assistance, Mavyret can cost hundreds or thousands of dollars per month at retail pharmacies. Discount programs offer some relief, but they don't come close to what a Patient Assistance Program provides, if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$14,500.00 | Save ~$14,430/mo |
| CVS Pharmacy | ~$14,000.00 | Save ~$13,930/mo |
| Walmart | ~$13,800.00 | Save ~$13,730/mo |
| Costco | ~$13,500.00 | Save ~$13,430/mo |
| Kroger | ~$13,200.00 | Save ~$13,130/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
Our Pricing:
Our advocacy service pricing is simple and predictable. The cost is based on the number of medications enrolled in our service — not on the retail price of your prescriptions. Most patients pay just $69.95/month for full advocacy on a single medication.
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Mavyret Prescription Program?
Hepatitis C is unique among the conditions we help patients access treatment for — because it’s curable. Unlike medications you take for the rest of your life, Mavyret is a finite course with a defined endpoint: being virus-free. But the window to cure is critical. The longer you wait, the more liver damage accumulates. When the only barrier between you and a cure is a $16,901 price tag, every month of delay is a month of preventable liver damage.
From the moment you enroll, your advocate takes full ownership of your case. They prepare your application, coordinate with your hepatologist or gastroenterologist to gather required documentation including genotype testing and liver function results, and track approval through every stage. Because hepatitis C treatment has a defined duration, your advocate ensures you receive your full course — 8, 12, or 16 weeks — without interruption.
Our pricing is simple and predictable: $69.95 per month — only for the months you’re actively in treatment. There are no hidden fees, no annual savings caps. While the medication is provided at no cost through the assistance program, our fee covers professional advocacy, application management,
doctor coordination, and treatment monitoring. If we’re unable to secure access, you won’t be charged.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through Afford My Prescriptions is the better long-term solution:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Manufacturer cards have $12,000 lifetime cap and require commercial insurance
- Still $12,900–$16,901 total cost with best discount
- Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95 for the treatment course — never changes
- Mavyret supplied at no medication cost through specialty pharmacy
- Medicare Part D patients accepted
- Total out-of-pocket cost for the full cure: as little as $140–$210
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income levels. Most programs follow guidelines that include a limit of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because these requirements can vary, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Mavyret Prescription From A Licensed U.S. Healthcare Provider
- You Have Been Diagnosed With Chronic Hepatitis C (Any Genotype)
- You Are Uninsured Or Underinsured And Cannot Afford Your Medication
- Medicare Part D Patients Welcome
Understanding Mavyret:
Mavyret (glecaprevir/pibrentasvir) is a once-daily prescription tablet used to treat chronic hepatitis C virus (HCV) infection in adults and children aged 3 years and older. Mavyret is pangenotypic — meaning it works against all six major hepatitis C genotypes — and can be used in patients with or without compensated cirrhosis. The standard regimen is three tablets taken together once daily with food for 8 weeks in most patients.
How It Works:
Mavyret cures Hepatitis C by using two specialized inhibitors to stop the virus from replicating inside liver cells. Glecaprevir blocks the enzyme responsible for processing viral proteins, while Pibrentasvir prevents the virus from copying its genetic material and assembling new particles. By attacking these two targets at once, the medication achieves a cure rate of 95%–98% across all genotypes.
Form and Use:
This medication is available as oral pellets for children or as 100 mg/40 mg tablets for adults. The standard adult treatment involves taking three tablets once daily with food for a period of 8 weeks. To ensure the treatment is effective, tablets should be taken at the same time each day and must be swallowed whole without being crushed, cut, or broken.
Generic Availability:
As of April 2026, there is no FDA-approved generic version of Mavyret available in the United States due to active patent protections. Because it remains a brand-only product, the cost for a full treatment course is high, ranging from $12,900 to $16,901. Patients must rely on the brand-name medication until a generic alternative is authorized for sale.
Warnings:
Mavyret carries a risk of reactivating the hepatitis B virus in co-infected patients, which can result in serious liver complications. It is also incompatible with specific medications, such as rifampin, atazanavir, or products containing ethinyl estradiol. Patients should inform their doctor of their full medical history, especially any previous hepatitis B infections, before starting treatment.
FAQ (Frequently Asked Questions)
How much does Mavyret cost without insurance?
A full 8-week treatment course (84 tablets) costs approximately $12,900–$16,901 without insurance. With the manufacturer’s savings card, commercially insured patients may pay as little as $5 per fill (with a $12,000 lifetime cap). Through AffordMyPrescriptions, qualifying patients receive the full treatment at no medication cost — our $69.95 monthly fee during
Is this the same Mavyret I'd get at a pharmacy?
Yes. The Mavyret provided through the Patient Assistance Program is the identical FDA- approved medication dispensed at any specialty pharmacy. The only difference is that you pay no medication cost.
Is there a generic version of Mavyret?
No. As of April 2026, there is no FDA-approved generic version of Mavyret in the United States. The medication remains under patent protection and is available only as the brand-name product.
Can I get Mavyret through the PAP if I have Medicare?
Yes. Medicare Part D patients are accepted into our advocacy program. With the 2026 Medicare Part D out-of-pocket cap of $2,100/year, our advocates can help you navigate Medicare coverage and find the most affordable pathway.
Does Mavyret actually cure hepatitis C?
Yes. Mavyret achieves a sustained virologic response (SVR) — meaning the virus is undetectable in your blood 12 weeks after completing treatment — in 95–98% of patients across all HCV genotypes. SVR is considered a cure. Once cured, the virus does not come back on its own, though reinfection through new blood-to-blood exposure is possible.
What if my application is denied?
Our Patient Advocates will immediately explore every alternative — including the manufacturer’s $5 copay savings card, independent co-pay assistance foundations for hepatitis C, insurance prior authorization appeals, state Medicaid hepatitis C coverage programs, and alternative hepatitis C treatments such as Epclusa. If we cannot secure assistance, you won’tbe charged.
Take Control of Your Medication Costs
If you are struggling with the high cost of Mavyret, our team may be able to help you
access assistance programs designed to make medications more affordable. Check
your eligibility today and take the first step toward reducing your prescription costs.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.